Mumbai-based pharmaceutical leader, Steris Healthcare, plans to launch its initial public offering (IPO) in FY 2026-27.Steris Healthcare announces a Rs 50 crore strategy to expand its operations into South India and double its production capacity.The company aims to solidify its national presence, deliver innovative healthcare solutions, and address critical therapeutic needs.The expansion is expected to generate 800 new jobs and the IPO will support further growth objectives.